Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Nascent Biotech News

    0,0853 $ -14,64% -0,0146 $
    In : 0,0798 € | 23.04.24 19:27:25 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    ISIN: US63108Q1013
    US-Symbol: NBIO
    Typ: Aktie

    Nascent Biotech News

    04.05.22 - ACCESSWIRE
    Nascent Biotech's CEO Sean Carrick Featured in In-Depth Interview with Proactive Investors
    VERO BEACH, FL / ACCESSWIRE / May 4, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology company ...
    12.04.22 - ACCESSWIRE
    Nascent Biotech and BioTools Partner in the Fight Against Cancer Using ROA to Define the Higher Order Structure of PTB, a Unique Monoclonal Antibody
    VERO BEACH, FL / ACCESSWIRE / April 12, 2022 / Nascent Biotech, developer of Pritumumab (PTB), a monoclonal antibody showing promise in the treatment of brain cancer, has ...
    08.03.22 - ACCESSWIRE
    The Laurel Amtower Cancer Institute and Neuro-Oncology Center at Sharp HealthCare to Join Innovative Antibody Brain Cancer Drug Trial
    SAN DIEGO, CA / ACCESSWIRE / March 8, 2022 / Sharp HealthCare, in collaboration with Nascent Biotech, Inc, announced today, its participation in a clinical trial for a novel ...
    23.02.22 - ACCESSWIRE
    Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical
    Milestone Payment is the Second of Four in $5M Pritumumab Licensing Deal
    11.01.22 - ACCESSWIRE
    Nascent Successfully Completes 2nd Cohort Dosing in Key Phase 1 Metastatic Brain Cancer Trial
    VERO BEACH, FL / ACCESSWIRE / January 11, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology ...
    13.07.21 - ACCESSWIRE
    Nascent Biotech and Manhattan BioSolutions Announce Promising Prelim/Preclinical Results in BCG-Based COVID-19 Vaccine Research Collaboration
    SAN DIEGO, CA / ACCESSWIRE / July 13, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a biotechnology company pioneering ...
    15.06.21 - ACCESSWIRE
    Marble Arch Research Publishes Analyst Research Report on Nascent Biotech
    VERO BEACH, FL / ACCESSWIRE / June 15, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology company ...
    08.06.21 - ACCESSWIRE
    Nascent Biotech Commencing Enrollment of Second Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancer
    SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology Company ...
    19.05.21 - ACCESSWIRE
    Nascent Biotech and BioRay Pharmaceutical Announce $5,000,000 Exclusive License Agreement for Development and Commercialization of Nascent's Pritumumab
    TAIZHOU, ZHEJIANG, CHINA & SAN DIEGO, CA / ACCESSWIRE / May 19, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) and BioRay Pharmaceutical Ltd., today announced that ...
    04.05.21 - ACCESSWIRE
    Nascent Biotech Continues Anti-Dilution Campaign with Preemptive Settlement of Outstanding Convertible Note
    SAN DIEGO, CA / ACCESSWIRE / May 4, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology company ...
    26.04.21 - ACCESSWIRE
    Nascent Biotech Announces Pre-emptive Elimination of Significant Tranche of Convertible Debt
    SAN DIEGO, CA / ACCESSWIRE / April 26, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology company ...
    31.03.21 - ACCESSWIRE
    Nascent Biotech Announces Initial Dosing Underway in Phase 1 Human Trial for Primary and Metastatic Brain Cancer
    SAN DIEGO, CA / ACCESSWIRE / March 31, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech," "Nascent," or the "Company"), a clinical-​stage biotechnology company ...
    24.03.21 - ACCESSWIRE
    Nascent Biotech Opens Phase 1 Human Trial to Evaluate Pritumumab as Treatment Option for Primary and Metastatic Brain Cancer
    SAN DIEGO, CA / ACCESSWIRE / March 24, 2021 /  Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology Company ...
    02.03.21 - ACCESSWIRE
    Nascent Biotech Earns US Patent for Crossing Blood-Brain Barrier
    SAN DIEGO, CA / ACCESSWIRE / March 2, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-​stage biotechnology Company ...
    17.02.21 - ACCESSWIRE
    Nascent Biotech Announces Successful Pritumumab In-Vitro Trial Data in Collaborative Covid-19 Treatment Study with Syracuse University
    SAN DIEGO, CA / ACCESSWIRE / February 17, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech" or the "Company"), a clinical-​stage biotech company pioneering the ...
    20.10.20 - ACCESSWIRE
    Nascent Biotech Announces Promising Covid-19 Invitro Study Results with Syracuse University Collaboration
    SAN DIEGO, CA / ACCESSWIRE / October 20, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech" or the "Company") is pleased to announce that the Company has ...
    07.10.20 - ACCESSWIRE
    Nascent Biotech Announces Key Personnel Additions in Preparation for Coming Phase One Clinical Studies
    SAN DIEGO, CA / ACCESSWIRE / October 7, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech" or the "Company") announces today that the Company is in the process ...
    01.10.20 - ACCESSWIRE
    Nascent Biotech Continues to Reduce Liabilities by Over $2.0 Million Dollars
    SAN DIEGO, CA / ACCESSWIRE / October 1, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) Announced today that It has continued to reduce its liabilities through stock conversion and ...
    23.09.20 - ACCESSWIRE
    Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies.
    SAN DIEGO, CA / ACCESSWIRE / September 23, 2020 / Nascent Biotech, Inc (OTCQB:NBIO), a biotechnology company pioneering innovative medicines to overcome difficult-​to-treat ...
    24.08.20 - ACCESSWIRE
    Nascent Biotech Inc Completes $740,000 Equity Round of Funding
    SAN DIEGO, CA / ACCESSWIRE / August 24, 2020 / Nascent Biotech, Inc (OTCQB:NBIO) announced today that it is closing on a direct private placement with aggregate proceeds of ...

    Newssuche

    Videos

    newspaper
    08:40 Uhr +7,82%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »